Logo image
In patients with acute HF and iron deficiency, IV ferric carboxymaltose improved quality of life at 4 to 24 wk
Journal article   Peer reviewed

In patients with acute HF and iron deficiency, IV ferric carboxymaltose improved quality of life at 4 to 24 wk

Anthony A Donato and Jared Green
Annals of internal medicine, v 174(10), JC110
Oct 2021
PMID: 34606316

Abstract

Anemia, Iron-Deficiency - drug therapy Ferric Compounds Humans Maltose - analogs & derivatives Heart Failure Quality of Life
Jankowska EA, Kirwan BA, Kosiborod M, et al. Eur Heart J. 2021;42:3011-20. 34080008.

Metrics

1 Record Views

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Cardiac & Cardiovascular Systems
Logo image